Instil Bio, Inc. financial data

Symbol
TIL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3963 Maple Avenue, Suite 350, Dallas, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.43K % +41.5%
Debt-to-equity 49.3 % +31.3%
Return On Equity -37.4 % +42.7%
Return On Assets -25.1 % +47.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.53M shares -95%
Common Stock, Shares, Outstanding 6.53M shares -95%
Entity Public Float 34.4M USD -88%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.51M shares +0.04%
Weighted Average Number of Shares Outstanding, Diluted 6.51M shares +0.04%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 20.7M USD -76.9%
General and Administrative Expense 44.7M USD -9.85%
Operating Income (Loss) -74.7M USD +63.2%
Nonoperating Income (Expense) -1.78M USD -311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -156M USD +30.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -75.2M USD +61.8%
Earnings Per Share, Basic -11.6 USD/shares +79%
Earnings Per Share, Diluted -11.6 USD/shares +79%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.66M USD -27%
Marketable Securities, Current 141M USD -35%
Other Assets, Current 1.96M USD
Assets, Current 133M USD -32.2%
Property, Plant and Equipment, Net 130M USD -6.66%
Operating Lease, Right-of-Use Asset 1.1M USD -58.7%
Goodwill 0 USD -100%
Other Assets, Noncurrent 6.18M USD +144%
Assets 273M USD -19.9%
Accounts Payable, Current 1.2M USD -27.4%
Employee-related Liabilities, Current 2.4M USD -27.1%
Liabilities, Current 10.3M USD -23.7%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 1.41M USD -57.1%
Other Liabilities, Noncurrent 8K USD -93%
Liabilities 96.2M USD -9.43%
Accumulated Other Comprehensive Income (Loss), Net of Tax -520K USD +0.95%
Retained Earnings (Accumulated Deficit) -643M USD -13.2%
Stockholders' Equity Attributable to Parent 176M USD -24.7%
Liabilities and Equity 273M USD -19.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.4M USD +58.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 9.24M USD -36.4%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 6.53M shares -95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.66M USD -34.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.73M USD +17.1%
Deferred Tax Assets, Valuation Allowance 127M USD +46.8%
Deferred Tax Assets, Gross 127M USD +44.3%
Operating Lease, Liability 3.17M USD -37.6%
Depreciation 3.9M USD -35%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -75.2M USD +61.9%
Lessee, Operating Lease, Liability, to be Paid 3.52M USD -36.8%
Property, Plant and Equipment, Gross 134M USD -7.92%
Operating Lease, Liability, Current 1.76M USD -1.95%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.2M USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.59M USD -19.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 349K USD -28.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.82M USD +43.1%
Deferred Tax Assets, Operating Loss Carryforwards 88.4M USD +51.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.34M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.22M USD -4.17%
Operating Lease, Payments 2.26M USD -8.18%
Additional Paid in Capital 820M USD +2.18%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 993K USD -44.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD -100%
Share-based Payment Arrangement, Expense 17.3M USD -14.5%
Interest Expense 6.55M USD +160%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%